INTRODUCTION AND OBJECTIVES: Up to 80% of patients with a diagnosis of nonobstructive azoospermia (NOA) have a negative result on genetic testing. We sequenced the exomes of a consanguineous Turkish family comprised of the mother and father, who are cousins, and their four sons. Two sons had NOA and two had chest wall deformities and oligospermia. Standard genetic testing revealed no karyotype abnormalities or Y microdeletions. Using whole exome sequencing (WES) data and homozygosity mapping we sought to investigate the genetic cause of abnormal semen parameters in the sons.
METHODS: Extraction of DNA was performed from blood samples followed by whole exome sequencing. Variants were annotated using the ANNOVAR software tool. The filter based annotation feature was used to assess variants for rarity, deleterious nature, conservation, and confirmed familial segregation as well as absence in the control population.
RESULTS: A non-synonymous mutation in "four-and-a-half lim domains 1" (FHL1) was identified in this consanguineous family from Turkey. This mutation in exon 6 (Xchr:135292164 G>A) of FHL1 is a nonsynonymous SNP and likely a disease-causing mutation as it is predicted to be damaging (SIFT 0.026, mutation taster score 1/D, and Polyphen2 0.846), is a rare variant (ExAC allele frequency of 1.11%), segregates with the disease, and is highly conserved (GERP 5.57) . Family segregation of the variants showed the presence of the homozygous mutation in the brothers with NOA and low sperm counts, heterozygous mutation in the mother, and homozygous wild type in the father indicating an X-linked inheritance pattern.
CONCLUSIONS: Using WES, we identified an X linked mutation in FHL1 as a likely disease-causing variant in a Turkish family with two sons diagnosed with NOA. Our data reinforce the clinical role of WES in the molecular diagnosis of highly heterogeneous genetic diseases, where conventional genetic approaches have previously failed to define a genetic diagnosis. INTRODUCTION AND OBJECTIVES: Non-obstructive azoospermia (NOA) is a cause of male infertility secondary to genetically driven defects in spermatogenesis. Testicular sperm extraction (TESE) is successful in identifying small number of sperm in 50% of men with NOA. During TESE, predominantly collapsed seminiferous tubules (ST) are identified with rare areas of dilated STs that are more likely to harbor viable sperm. Hence we hypothesize that miRNA regulated control of mRNA expression along STs leads to optimal environments for spermatogenesis within the human testis.
METHODS: STs were obtained from 7 patients, including 3 with NOA, and 2 patients with Sertoli-cell only (SCO). In the three NOA patients, single STs were cut based on the differences in diameter along the same ST into: full/dilated or empty/collapsed tubules. Quantitative PCR was performed on all tubules for GFRa1 and values expressed per vimentin and clusterin. ACTB was used as a housekeeping gene. Expression of GFRa1 was corrected for number of Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e189
Sertoli cells (vimentin/clusterin). MiRNA expression profiles were determined for each segment of STs and normalized to let-7a. GenEx software was used to identify differentially expressed miRNAs using adjusted p<0.0007 and minimum of 2-fold difference. RESULTS: Quantitative PCR showed a statistically significant decrease in the relative expression of GFRa1 between dilated and collapsed STs (p<0.001) indicating an abnormal number of spermatogonial stem cells (SSC) or spermatogonia. A set of 12 miRNA were identified to be differentially expressed and linked to known signaling pathways in Sertoli cells and SSCs CONCLUSIONS: Our data supports the hypothesis that unique miRNA profiles support normal SSC division that correlate into islands of spermatogenesis, especially in men with NOA. This data in conjunction with previous observations that SSCs are likely present in patients with SCO offers new targets for further research and possible therapeutic intervention INTRODUCTION AND OBJECTIVES: Non-obstructive azoospermia due to testicular failure can be histologically classified into 3 phenotypes: sertoli cell only (SCO), early maturation arrest (eMA), and late maturation arrest (lMA). Genetics of NOA is largely unknown and identification of genetic mutations leading to NOA has been inconclusive. In our study, we focused on large scale exome sequencing in testicular tissue from men with NOA to determine candidate genes for mechanistic, diagnostic and therapeutic evaluation.
METHODS: Total RNA was extracted from tissue harvested from testicular biopsy. 37 patients with non-obstructive azoospermia (NOA) and 3 histologic phenotypes: SCO, eMA, lMA as well as normal controls (NL). RNA libraries were sequenced on an Illumina HiSeq 2000 platform. Results were mapped to the genome and transcriptome using TopHat (v2.0.8). Cufflinks was then used to quantify the number of reads. RNA Seq data was expressed as FPKMs and normalized using TMM. JMP genomics was used to identify differentially expressed (DE) transcripts at FDR ¼ 0.001. Due expected loss of specific germ cells populations in lMA, eMA, and SCO syndrome, we focused our analysis on overexpressed transcripts in each histological category as compared to NL control.
RESULTS: Among 21,879 mapped transcripts 10,777 were DE between SCO and NLs. Using a contingency analysis, 6,169 genes were DE between eMA and normal when compared to SCO and normal DE (p<0.0001), and are likely involved in entry into meiosis and function of primary spermatocytes. Most overexpressed and DE genes include: JUN, BTG2, and RASAL1, which are expressed in the testis and previously described to regulate cell cycle and proliferation. 30 genes were DE between lMA and NL but not DE between NL and eMA, suggesting a mechanistic role in lMA as they are not due to loss of spermatids or spermatozoa. Here, most DE genes include SMIM8, SNF280C and OTUD6A and are exclusively expressed in testis based on GEO human tissues expression profile. To validate our analytical approach, we demonstrated a loss of SYCP3 (marker of primary spermatocytes) in SCO and down regulation of PRM1 (spermatids) in SCO, eMA, and lMA compared to NL. Expression of SOX9 (Sertoli marker) and INSL3 (Leydig marker) were similar across all groups.
CONCLUSIONS: Using whole exome sequencing to directly compare DE of genes among the differing phenotypes of SCO, eMA, and lMA have allowed us to identify active gene transcripts localized to specific stages of arrested spermatogenesis. Additionally, we identified a small subset of genes which are over expressed, potentially contributing to the pathology of NOA. 
